Document is current
Any future updates will be listed below
-
Authors
Diaz-Hurtado, Marcos https://orcid.org/0000-0003-1528-5873
MartÃnez-Heras, Eloy https://orcid.org/0000-0001-9937-3162
Solana, Elisabeth https://orcid.org/0000-0001-7973-2439
Casas-Roma, Jordi https://orcid.org/0000-0002-0617-3303
Llufriu, Sara https://orcid.org/0000-0003-4273-9121
Kanber, Baris https://orcid.org/0000-0003-2443-8800
Prados, Ferran https://orcid.org/0000-0002-7872-0142
- License Information
-
More Information
Article History
Received: 29 March 2022
Accepted: 12 July 2022
First Online: 22 July 2022
Declarations
:
: M.D.-H., E.M.-H., J.C.-R., B.K. and F.P. have nothing to disclose. E.S received travel reimbursement from Sanofi. S.L. received compensation for consulting services and speaker honoraria from Biogen Idec, Novartis, TEVA, Genzyme, Sanofi and Merck.
: This study has been approved by the Ethics Committee of the University Oberta de Catalunya (UOC) stating that this research does not include human subject participation or any processing of personal data and the research fulfils current legislation on data protection.
: This research does not include human subject participation or any processing of personal data.
: All authors consent for publication of this paper.
